Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy of the Neoadjuvant Chemotherapy for IB2 and IIA2 Stage Cervical Cancer Patients, A Multicenter, Prospective and Randomized Controlled Trial

NCT03308591 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

NCT NCT03308591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03308591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy of the Neoadjuvant Chemotherapy for IB2 and IIA2 Stage Cervical Cancer Patients, A Multicenter, Prospective and Randomized Controlled Trial
Lead sponsor
Huazhong University of Science and Technology
Phase
Phase 3
Overall status
Completed
Start date
January 11, 2016
Completion date
February 1, 2022
Enrollment
774 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, uterine cervical cancer, uterine cervical neoplasm